Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer

Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. In addition, both thrombotic relapse and major haemorrhages derived from VTD tre...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Transl Oncol
Hoofdauteurs: Quintanar, T., Font, C., Gallardo, E., Barba, R., Obispo, B., Díaz-Pedroche, C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2020
Onderwerpen:
Special Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979662/
https://ncbi.nlm.nih.gov/pubmed/32885400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-020-02477-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items